Post-refractive IOL Outcomes With Clareon TruPlus

Part of paid clinical trials in Greensboro, North Carolina.

Sponsor
Laser Defined Vision
Study ID
NCT07610226
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Cataract

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Clareon TruPlus — DEVICE
    Clareon TruPlus

Study Details

This is a prospective, single-arm, single-center, single-surgeon study evaluating the Clareon TruPlus IOL in post-refractive cataract patients. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the PRISQ Questionnaire.

Key Dates

Start date
Jun 23, 2026
Status verified
May 2026
Primary completion
Jun 23, 2027
Completion
Jun 23, 2027

Study Design

Enrollment
35 participants (estimated)

Arms

  • Arm: Clareon TruPlus

Primary Outcome Measure

Binocular photopic BCDVA (4m) [ Time Frame: 3 months postoperatively ]

Locations (1)

FacilityCityStateZIPSite coordinators
Physicians ProtocolGreensboroNorth Carolina27401
Carrie Williams
[email protected]
336-288-8823
Karl Stonecipher, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Greensboro, NC

By research site
Physicians Protocol· Greensboro, NC

Related Studies